Overview
Psychostimulant dependence in remission refers to the state where an individual has ceased active substance use but remains at risk for relapse and may experience withdrawal symptoms or psychological cravings 1.Diagnosis
Clinical history of chronic psychostimulant use
Absence of active substance use confirmed through toxicology screens 1
Presence of withdrawal symptoms or heightened sensitivity to stress 1
Psychological assessment for cravings and mood disturbances 1Management
Cognitive-behavioral therapy (CBT) as first-line psychological intervention 1
Adjunctive pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) for co-occurring depression or anxiety 1
Monitoring and support groups to reduce relapse risk 1Special Populations
No specific evidence provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1Key Recommendations
Utilize cognitive-behavioral therapy for managing psychostimulant dependence in remission (Evidence: Moderate) 1
Consider selective serotonin reuptake inhibitors for co-morbid mood disorders (Evidence: Moderate) 1
Implement structured support programs to enhance long-term recovery outcomes (Evidence: Expert opinion) 1References
1 Amendt HL, Siedenburg JS, Steffensen N, Söbbeler FJ, Schütter A, Tünsmeyer J et al.. Transcranial magnetic stimulation with acepromazine or dexmedetomidine in combination with levomethadone/fenpipramide in healthy Beagle dogs. Veterinary journal (London, England : 1997) 2016. link